89 related articles for article (PubMed ID: 12687260)
41. Nrf2 Negatively Regulates Type I Interferon Responses and Increases Susceptibility to Herpes Genital Infection in Mice.
Gunderstofte C; Iversen MB; Peri S; Thielke A; Balachandran S; Holm CK; Olagnier D
Front Immunol; 2019; 10():2101. PubMed ID: 31555293
[TBL] [Abstract][Full Text] [Related]
42. Herpes virus-specific immune responses in individuals experiencing recurrent genital herpes.
Boswell CM; Duncan IA; Uttridge J; Sonnex C; Hickling JK
Biochem Soc Trans; 1997 May; 25(2):278S. PubMed ID: 9191322
[No Abstract] [Full Text] [Related]
43. Evasion of the mucosal innate immune system by herpes simplex virus type 2.
Peng T; Zhu J; Klock A; Phasouk K; Huang ML; Koelle DM; Wald A; Corey L
J Virol; 2009 Dec; 83(23):12559-68. PubMed ID: 19793807
[TBL] [Abstract][Full Text] [Related]
44. High interferon alpha levels in placenta, maternal, and cord blood suggest a protective effect against intrauterine herpes simplex virus infection.
Zdravkovic M; Knudsen HJ; Liu X; Hager H; Zachar V; Aboagye-Mathiesen G; Ebbesen P
J Med Virol; 1997 Mar; 51(3):210-3. PubMed ID: 9139085
[TBL] [Abstract][Full Text] [Related]
45. Immune and Interferon Status in Newborns after Viferon Treatment of Pregnant Women with Cytomegalovirus and Herpes Infection.
Tareeva TG; Antipova II; Malinovskaya VV; Suskova VS; Abaeva ZR; Axenov AN
Russ J Immunol; 2000 Jul; 5(2):193-202. PubMed ID: 12687175
[TBL] [Abstract][Full Text] [Related]
46. Cutting Edge: Genetic Association between IFI16 Single Nucleotide Polymorphisms and Resistance to Genital Herpes Correlates with IFI16 Expression Levels and HSV-2-Induced IFN-β Expression.
Eriksson K; Svensson A; Hait AS; Schlüter K; Tunbäck P; Nordström I; Padyukov L; Liljeqvist JÅ; Mogensen TH; Paludan SR
J Immunol; 2017 Oct; 199(8):2613-2617. PubMed ID: 28893956
[TBL] [Abstract][Full Text] [Related]
47. Recurrent herpes genitalis, severe impairment of specific cell-mediated immune response and bilateral femoral head necrosis: report of a case.
Sirianni MC; Soddu S; Bonomo R; Panà A
Boll Ist Sieroter Milan; 1986; 65(1):78-83. PubMed ID: 2941035
[TBL] [Abstract][Full Text] [Related]
48. [The interferon status in recurrent genital herpes].
Malinovskaia VV; Temicheva EV; Panasiuk AF; Semenova TB
Vopr Virusol; 1991; 36(3):254-6. PubMed ID: 1716394
[No Abstract] [Full Text] [Related]
49. Effect of antibody to interferon on genital herpesvirus infection in mice.
Wrzos H; Murasko DM; Rapp F
Microb Pathog; 1986 Feb; 1(1):71-8. PubMed ID: 3508484
[TBL] [Abstract][Full Text] [Related]
50. [Comparative estimation of the indicators of interferon, immune, and cytokine states in the comprehensive study of patients with herpesvirus infections].
Mel'nichenko AV; Mezentseva MV; Shapoval IM; Tregubova MI; Podcherniaeva RIa; L'vov ND
Vopr Virusol; 2011; 56(6):33-6. PubMed ID: 22359947
[TBL] [Abstract][Full Text] [Related]
51. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma.
Raqib R; Wretlind B; Andersson J; Lindberg AA
J Infect Dis; 1995 Feb; 171(2):376-84. PubMed ID: 7531208
[TBL] [Abstract][Full Text] [Related]
52. Investigating the Safety and Efficacy of the Synthetic Drug Herbix on Immune Responses Involved in the Treatment of a Mouse Model of Herpes Simplex Virus.
Khodadoust MA; Keramatian GR; Kaffash Farkhad N; Tavakol-Afshari J
Iran J Allergy Asthma Immunol; 2023 Feb; 22(1):72-81. PubMed ID: 37002632
[TBL] [Abstract][Full Text] [Related]
53. [Therapy of genital herpes with interferon].
Danilow LN
Zentralbl Gynakol; 1984; 106(5):331-3. PubMed ID: 6202080
[TBL] [Abstract][Full Text] [Related]
54. [Cellular immunity mechanisms in genital herpes].
Grebeniuk VN; Konstantinova IB
Vestn Dermatol Venerol; 1982 Jul; (7):36-42. PubMed ID: 6753406
[No Abstract] [Full Text] [Related]
55. Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individuals with known date of seroconversion.
Suligoi B; Dorrucci M; Volpi A; Andreoni M; Pezzotti P; Rezza G;
AIDS; 2001 Jan; 15(1):133-5. PubMed ID: 11192860
[No Abstract] [Full Text] [Related]
56. The immune system and its control: a possible model in herpes virus infections.
Green MD; Locke SE
J Clin Psychopharmacol; 1988 Feb; 8(1):68-9. PubMed ID: 3351004
[No Abstract] [Full Text] [Related]
57. [Immunity indicators and the degree of adenosine deaminase activity in patients with pulmonary tuberculosis].
Knoring BE; Titarenko OT; Sakharova IIa; Loginova GP; D'iakova ME; Perova TL; Simbirtsev AS; Pigareva NV; Kotov AIu
Probl Tuberk; 2002; (7):32-6. PubMed ID: 12561640
[No Abstract] [Full Text] [Related]
58. Immune parameters in patients with asthma.
Chopey IV; Debretseni KO; Hechko MM; Chubirko KI; Myhovych II
Wiad Lek; 2014; 67(2 Pt 2):145-7. PubMed ID: 25796811
[TBL] [Abstract][Full Text] [Related]
59. Atypical Herpes Simplex Presenting Necrotizing Granulomas in an Immunocompromised Patient.
Martinez-Mera C; Hospital M; López-Negrete E; Suarez Massa D
Am J Dermatopathol; 2020 Apr; 42(4):305-306. PubMed ID: 31188142
[No Abstract] [Full Text] [Related]
60. [Advances in the research on cellular factors].
Peng DZ; Huang WH
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Mar; 9(2):127-30. PubMed ID: 7693315
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
